Onconetix, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEARSOnconetix, Inc.ONCO3d

   Onconetix, Inc. filed ARS on 2026-10-16.

   • Form ARS filed on 2026-10-16.
   • Company name: Onconetix, Inc.
   • Ticker: ONCO.
2. ROUTINEDEF 14AOnconetix, Inc.ONCOOct 8

   Onconetix to hold annual meeting on Nov 10

   • Annual meeting on Nov 10, 2026 at 9:00 a.m. Eastern Time.
   • Re-elect Josh Epstein as Class II director for 3-year term.
   • Approve issuance of up to 154,856,150 shares of Common Stock upon conversion of Series F Preferred Stock.
3. ROUTINEPRE 14AOnconetix, Inc.ONCOSep 17

   Preliminary proxy statement

4. ROUTINEDEFA14AOnconetix, Inc.ONCOSep 14

   Additional proxy materials

5. ROUTINE8-KOnconetix, Inc.ONCOSep 14

   Current report

6. ROUTINE425Onconetix, Inc.ONCOSep 14

   Merger communication

7. ROUTINE424B3Onconetix, Inc.ONCOSep 8

   Securities offering

8. ROUTINEEFFECTOnconetix, Inc.ONCOSep 4

   Registration declared effective

9. ROUTINE425Onconetix, Inc.ONCOSep 3

   Merger communication

10. ROUTINES-1/AOnconetix, Inc.ONCOAug 31

    Securities offering (amended)

11. NOTABLE10-QOnconetix, Inc.ONCOAug 13

    Quarterly report

12. NOTABLES-1Onconetix, Inc.ONCOAug 12

    Securities offering

13. ROUTINE425Onconetix, Inc.ONCOAug 6

    Merger communication

14. ROUTINE8-KOnconetix, Inc.ONCOJul 29

    Current report

15. ROUTINESCHEDULE 13GOnconetix, Inc.ONCOJul 27

    Ownership stake disclosure by KEYSTONE CAPITAL PARTNERS, LLC

    KEYSTONE CAPITAL PARTNERS, LLC, filed by

16. ROUTINE425Onconetix, Inc.ONCOJul 7

    Merger communication

17. ROUTINE425Onconetix, Inc.ONCOJun 24

    Merger communication

18. ROUTINE424B3Onconetix, Inc.ONCOJun 17

    Securities offering

19. ROUTINEEFFECTOnconetix, Inc.ONCOJun 17

    Registration declared effective

20. ROUTINE8-KOnconetix, Inc.ONCOMay 19

    Current report

21. NOTABLE10-QOnconetix, Inc.ONCOMay 13

    Quarterly report

22. ROUTINEEFFECTOnconetix, Inc.ONCOMay 12

    Registration declared effective

23. ROUTINEEFFECTOnconetix, Inc.ONCOMay 8

    Registration declared effective

24. ROUTINES-1/AOnconetix, Inc.ONCOMay 7

    Securities offering (amended)

25. ROUTINE8-KOnconetix, Inc.ONCOMay 4

    Current report

26. NOTABLES-1Onconetix, Inc.ONCOApr 28

    Securities offering

27. ROUTINE8-KOnconetix, Inc.ONCOApr 24

    Current report

28. ROUTINE4Onconetix, Inc.ONCOApr 22

    HRT FINANCIAL LP, insider filing for ONCO

    HRT FINANCIAL LP, reporting

29. ROUTINE4Onconetix, Inc.ONCOApr 21

    HRT FINANCIAL LP, insider filing for ONCO

    HRT FINANCIAL LP, reporting

30. ROUTINE4Onconetix, Inc.ONCOApr 16

    2 insider filings

    HRT FINANCIAL LP, insider filing for ONCO

    Show all 2

    • 4Insider filing for ONCOApr 16
    • 3New insider at ONCOApr 16

    HRT FINANCIAL LP, reporting

31. ROUTINE425Onconetix, Inc.ONCOApr 9

    Merger communication

32. ROUTINE425Onconetix, Inc.ONCOApr 2

    Merger communication

33. ROUTINE425Onconetix, Inc.ONCOMar 31

    Merger communication

34. ROUTINEDEF 14AOnconetix, Inc.ONCOMar 30

    Proxy statement

35. ROUTINE3Onconetix, Inc.ONCOMar 27

    2 insider filings

    David Allan White, new insider at ONCO

    Show all 2

    • 3New insider at ONCOMar 27
    • 3New insider at ONCOMar 27

    David Allan White, reporting

36. ROUTINE425Onconetix, Inc.ONCOMar 25

    Merger communication

37. ROUTINE8-K/AOnconetix, Inc.ONCOMar 25

    Current report (amended)

38. ROUTINE8-KOnconetix, Inc.ONCOMar 24

    Current report

39. ROUTINEPRE 14AOnconetix, Inc.ONCOMar 18

    Preliminary proxy statement

40. NOTABLE10-KOnconetix, Inc.ONCOMar 13

    Annual report

41. ROUTINE425Onconetix, Inc.ONCOFeb 12

    Merger communication

42. ROUTINE8-KOnconetix, Inc.ONCOFeb 12

    Current report

43. ROUTINE8-KOnconetix, Inc.ONCOFeb 9

    Current report

44. ROUTINEDEF 14AOnconetix, Inc.ONCOJan 2

    Proxy statement

45. ROUTINEEFFECTOnconetix, Inc.ONCODec 29, 2025

    Registration declared effective

46. ROUTINE424B3Onconetix, Inc.ONCODec 23, 2025

    Securities offering

47. ROUTINEPRE 14AOnconetix, Inc.ONCODec 22, 2025

    Preliminary proxy statement

48. ROUTINE3Onconetix, Inc.ONCODec 12, 2025

    Sarah Romano, new insider at ONCO

    Sarah Romano, reporting

Older filings on EDGAR